home · filing · 0001193125-22-274998
8-K
filed November 1, 2022, 7:59 PM ET
ticker UTL
CIK 0000755001
leadership
confidence high
sentiment neutral
materiality 0.30
Unitil elects Dr. Neveen Awad to Board of Directors, effective Oct 26, 2022
UNITIL CORP
Dr. Awad elected as independent director; will serve until 2023 annual meeting and stand for re-election.
She is a partner and managing director at Boston Consulting Group, leading Detroit office and global Technology Platform.
Appointed to Compensation Committee; receives $65k annual cash retainer plus $80k equity retainer.
Part of normal succession planning for upcoming retirements due to mandatory director age of 75.
Dr. Awad owned no shares and has no disclosable relationships with the company.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Dr. Neveen F. Awad
Director
Effective 2022-10-26
Filed November 1, 2022, 7:59 PM ET
On October 26, 2022, the Board of Directors of Unitil Corporation (the “Company”) elected Dr. Neveen F. Awad as a Director, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dr. Neveen F. Awad was elected as Director at UNITIL CORP.
Action elected
Role Director
Exact text from the filing
On October 26, 2022, the Board of Directors of Unitil Corporation (the “Company”) elected Dr. Neveen F. Awad as a Director, effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-22-274998
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.